Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
1.32M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-606K
-
Total reported value, excl. options
-
$0
-
Value change
-
-$10.1M
-
Number of sells
-
-24
Significant Holders of PIERIS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (PIRS) as of Q4 2024
24 filings reported holding PIRS - PIERIS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value as of Q4 2024.
PIERIS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (PIRS) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 1.32M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include US BANCORP \DE\ (0 shares), Allworth Financial LP (0 shares), BlackRock, Inc. (0 shares), CM Management, LLC (0 shares), Truvestments Capital LLC (0 shares), VANGUARD GROUP INC (0 shares), ACADIAN ASSET MANAGEMENT LLC (0 shares), JPMORGAN CHASE & CO (0 shares), CITIGROUP INC (0 shares), and BML Capital Management, LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.